A practical reference on Research chemical: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-27 and is reviewed periodically as new material appears.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516; GW-1516; endurobol | GW501516 is the research code |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator |
| Molecular formula | C21H18F3NO3S2 | Established chemical formula |
| Molar mass | 453.5 g/mol | Calculated from the formula |
| Regulatory status | Prohibited in sport; not approved as medicine | Status varies by country |
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
==== Coral bleaching ==== The Pacific Marine Environmental Laboratory attributes the first large-scale coral bleaching event in 1997–1998 to the warming waters of the concurrent El Niño event with possible contribution from anthropogenic climate change. Most critically, global mass bleaching events were recorded in 1997–98 and 2015–16, when around 75–99% losses of live coral were registered across the world. Considerable attention was also given to the collapse of Peruvian and Chilean anchovy populations that led to a severe fishery crisis following the ENSO events in 1972–73, 1982–83, 1997–98 and, more recently, in 2015–16. In particular, increased surface seawater temperatures in 1982-83 also lead to the probable extinction of two hydrocoral species in Panamá, and to a massive mortality of kelp beds along 600 km of coastline in Chile, from which kelps and associated biodiversity slowly recovered in the most affected areas even after 20 years. All these findings enlarge the role of ENSO events as a strong climatic force driving ecological changes all around the world – particularly in tropical forests and coral reefs.
A relatively short-range dating technique is based on the decay of uranium-234 into thorium-230, a substance with a half-life of about 80,000 years. It is accompanied by a sister process, in which uranium-235 decays into protactinium-231, which has a half-life of 32,760 years. While uranium is water-soluble, thorium and protactinium are not, and so they are selectively precipitated into ocean-floor sediments, from which their ratios are measured. The scheme has a range of several hundred thousand years. A related method is ionium–thorium dating, which measures the ratio of ionium (thorium-230) to thorium-232 in ocean sediment.
=== Antifungal activity === Lactoferrin and lactoferricin inhibit in vitro growth of Trichophyton mentagrophytes, which are responsible for several skin diseases such as ringworm. Lactoferrin also acts against the Candida albicans – a diploid fungus (a form of yeast) that causes opportunistic oral and genital infections in humans. Fluconazole has long been used against Candida albicans, which resulted in emergence of strains resistant to this drug. However, a combination of lactoferrin with fluconazole can act against fluconazole-resistant strains of Candida albicans as well as other types of Candida: C. glabrata, C. krusei, C. parapsilosis and C. tropicalis. Antifungal activity is observed for sequential incubation of Candida with lactoferrin and then with fluconazole, but not vice versa. The antifungal activity of lactoferricin exceeds that of lactoferrin. In particular, synthetic peptide 1–11 lactoferricin shows much greater activity against Candida albicans than native lactoferricin. Administration of lactoferrin through drinking water to mice with weakened immune systems and symptoms of aphthous ulcer reduced the number of Candida albicans strains in the mouth and the size of the damaged areas in the tongue. Oral administration of lactoferrin to animals also reduced the number of pathogenic organisms in the tissues close to the gastrointestinal tract. Candida albicans could also be completely eradicated with a mixture containing lactoferrin, lysozyme and itraconazole in HIV-positive patients who were resistant to other antifungal drugs.
1973); British-Israeli politician, media expert, journalist, media-spokesperson, policy maker; Deputy Mayor of Jerusalem in charge of foreign relations, international economic development and tourism; co-founder of UAE–Israel Business Council; appointed by Israel's foreign minister Eli Cohen as special envoy for innovation; has written editorials, commentary, and op-ed columns for The Telegraph, Jerusalem Post, La Voz de Galicia, Times of Israel, Haaretz, Ynet News, Gulf Business, Arutz Sheva/Israel National News, Algemeiner Journal, Jewish Journal (Los Angeles), Jewish News, JNS, Jüdische Allgemeine, Salem Radio Network News, The Media Line, The Detroit Jewish News, Jewish Policy Center, Israel Behind The News, The Jewish World, Jewish Chronicle; previously served as president of King's College Jewish Society; was barrister at Middle Temple; served as campaign director at World Jewish Relief; served as senior associate with American Jewish Joint Distribution Committee; CEO of international strategic communications firm, Message Experts; worked with U.S. State Department on embassy in Jerusalem; one of founders of UAE–Israel Business Council. Dan Neidle (b.
In the United States, fire and hot liquids are the most common causes of burns. Of house fires that result in death, smoking causes 25% and heating devices cause 22%. Almost half of injuries are due to efforts to fight a fire. Scalding is caused by hot liquids or gases and most commonly occurs from exposure to hot drinks, high temperature tap water in baths or showers, hot cooking oil, or steam. Scald injuries are most common in children under the age of five and, in the United States and Australia, this population makes up about two-thirds of all burns. Contact with hot objects is the cause of about 20–30% of burns in children. Generally, scalds are first- or second-degree burns, but third-degree burns may also result, especially with prolonged contact. Fireworks are a common cause of burns during holiday seasons in many countries. This is a particular risk for adolescent males. In the United States, for non-fatal burn injuries to children, white males under the age of 6 comprise most cases. Thermal burns from grabbing/touching and spilling/splashing were the most common type of burn and mechanism, while the bodily areas most impacted were hands and fingers followed by head/neck.
Sources: en.wikipedia.org
== Further reading == Virginia Ott (November 1976). Man with a Million Ideas: Fred Jones, Genius/Inventor. Lerner Publications Company. ISBN 978-0-822-50761-1. Gloria M. Swanson, Margaret V. Ott (1994). I've Got an Idea: The Story of Frederick McKinley Jones (reprint ed.). Lerner Publishing Group. p. 95. ISBN 0-82259-662-8.
Starring a principal cast of Josh Hartnett, Bruce Willis, Lucy Liu, Stanley Tucci, and Ben Kingsley, the film garnered mixed reception. David Mattin of BBC wrote: "Kingsley and Freeman shine individually, but their inevitable, climactic clash of heads lacks force. Like its leading man [Hartnett], this movie presents a charming façade with nothing much underneath." Next, Freeman portrayed himself in the low-budget comedy 10 Items or Less opposite Paz Vega. Two weeks after its theatrical release, 10 Items or Less was made available for download from ClickStar, a film distribution company that Freeman co-founded that year. In 2007, Freeman reprised his role as God in Evan Almighty, a sequel to 2003's Bruce Almighty, with Steve Carell. Evan Almighty was a box-office failure and negatively received; The Guardian critic wrote: "A cast full of people who have been frequently funny elsewhere flounder in this deluge of sentimentality and CGI. Avoid like the Ten Plagues." The drama Feast of Love was Freeman's second release of 2007. It is based on the 2000 novel The Feast of Love by Charles Baxter, about a group of friends living in suburban Oregon who come into contact with a free spirit who changes their outlook on life; Peter Bradshaw of The Guardian sarcastically remarked that it was great to see Freeman in a challenging role. Freeman had a supporting part in Gone Baby Gone (2007), a mystery thriller that was also Ben Affleck's directorial debut. Adapted from the 1998 novel of the same name by Dennis Lehane, Freeman plays Captain Jack Doyle of the Boston Police Department.
The first known archaeological evidence of usage was in Kariandusi (Kenya) and other sites of the Acheulian age (beginning 1.5 million years BP) dated 700,000 BC, although only very few objects have been found at these sites relative to the Neolithic. Manufacture of obsidian bladelets at Lipari had reached a high level of sophistication by the late Neolithic, and was traded as far as Sicily, the southern Po river valley, and Croatia. Obsidian bladelets were used in ritual circumcisions and cutting of umbilical cords of newborns. Anatolian sources of obsidian are known to have been the material used in the Levant and modern-day Iraqi Kurdistan from a time beginning sometime about 12,500 BC. Obsidian artifacts are common at Tell Brak, one of the earliest Mesopotamian urban centers, dating to the late fifth millennium BC. Obsidian was valued in Stone Age cultures because, like flint, it could be fractured to produce sharp blades or arrowheads in a process called knapping. Like all glass and some other naturally occurring rocks, obsidian breaks with a characteristic conchoidal fracture. It was also polished to create early mirrors. Modern archaeologists have developed a relative dating system, obsidian hydration dating, to calculate the age of obsidian artifacts.
Nicotinamide mononucleotide adenylyltransferase 3 (NMNAT3) is an enzyme that in humans is encoded by the NMNAT3 gene. NMNAT3 is the third of three protein isoforms of nicotinamide-nucleotide adenylyltransferase (NMNAT) found in humans. As with the other NMNATs, NMNAT3 is an enzyme that catalyzes nicotinamide adenine dinucleotide (NAD) synthesis. NMNAT3 levels are highest in liver, heart, skeletal muscle, and erythrocytes.
=== Imaging === The SBP-Tag will also bind to streptavidin or streptavidin reagents in solution. Applications of these engineered associations include the visualization of specific proteins within living cells, monitoring of the kinetics of the translation of individual proteins in an in vitro translation system, control of the integration of a multi-spanning membrane protein into the endoplasmic reticulum by fusing the SBP-Tag to the N-terminal translocation sequence and then halting integration with streptavidin and restarting integration with biotin. Fluorescent streptavidin reagents (e.g. streptavidin-HRP) can be used to visualize the SBP-tag by immunoblotting of SDS-PAGE. Additionally, antibodies to the SBP-tag are available commercially.
Sources: en.wikipedia.org
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.
No. It has no approved medical indication in any country. Regulatory agencies have not cleared it for treatment or prevention of any condition.
Early clinical work stopped after rodent carcinogenicity findings. Those animal results raised concerns about long-term human risk, although direct human evidence is lacking. The human relevance of the tumors remains an open scientific question.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.